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Abstract
Many drugs have intracellular or membrane-associated targets thus understanding their interaction with 
the cell membrane is of value in drug development. Cell-free tools used to predict membrane interactions 
should replicate the molecular organization of the membrane. Microcavity array supported lipid bilayer 
(MSLB) platform are versatile biophysical models of the cell membrane that combine liposome-like 
membrane fluidity with stability and addressability. We used an MSLB herein to interrogate drug-
membrane interactions across seven drugs from different classes, including non-steroidal anti-
inflammatories; Ibuprofen (Ibu) and Diclofenac (Dic), antibiotics; Rifampicin (Rif), Levofloxacin (Levo) 
and Pefloxacin (Pef), and bisphosphonates; Alendronate (Ale) and Clodronate (Clo). Fluorescence 
lifetime correlation spectroscopy (FLCS) and electrochemical impedance spectroscopy (EIS) were used to 
evaluate the impact of drug on DOPC and binary bilayers over physiologically relevant drug 
concentrations.  Whereas FLCS data revealed Ibu, Levo, Pef, Ale and Clo had no impact on lipid lateral 
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2mobility, EIS which is more sensitive to membrane structural change, indicated modest but significant 
decreases to membrane resistivity consistent with adsorption but weak penetration of drugs at the 
membrane. Ale and Clo, evaluated at pH 5.25, did not impact the impedance of the membrane except at 
concentrations exceeding 4mM.  Conversely, Dic and Rif dramatically altered bilayer fluidity, suggesting 
their translocation through the bilayer and, EIS data, showed resistivity of the membrane decreased 
substantially with increasing drug concentration. Capacitance changes to the bilayer in most cases were 
insignificant. Using a Langmuir-Freundlich model to fit the EIS data, we propose Rsat as an empirical 
value that reflects permeation.  Overall, the data indicate that Ibu, Levo, and Pef, adsorb at the interface of 
the lipid membrane but Dic and Rif interact strongly, permeating the membrane core modifying the 
water/ion permeability of the bilayer structure. These observations are discussed in the context of 
previously reported data on drug permeability and Log P.
Keywords: Microcavity supported lipid bilayer (MSLB), Fluorescence lifetime correlation spectroscopy 
(FLCS), Electrochemical impedance spectroscopy (EIS), Lipid diffusivity, Fluorescent lifetime and 
Molecular brightness, Membrane permeabilization
Abbreviations: Ibu – Ibuprofen; Dic – Diclofenac; Rif-Rifampicin; ATTO – DOPE-Atto655, BODIPY – 
β-BODIPY-C5-HPC; MSLB – microcavity supported lipid bilayer; FLCS – fluorescence lifetime 
correlation spectroscopy; EIS – electrochemical impedance spectroscopy; MH - 6-mercapto-1-hexanol; 
DOPC – 1,2-dioleoyl-sn-glycero-3-phosphocholine; DMPC – 1,2-dimyristoyl-sn-glycero-3-
phosphocholine; τi – fluorescent lifetime; MB – Molecular brightness     
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3Introduction
Irrespective of it’s target, a drug must typically cross numerous membrane structures within an organism, 
following its administration. Understanding the extent and structural basis of interaction of 
pharmaceuticals with the lipid membrane is crucial in drug discovery as such information can aid in 
predicting membrane permeability or membrane-associated toxicity during the design of drugs with 
intracellular targets.1–3 The cellular membranes are semi-permeable barriers comprised of complex 
matrices of the phospholipid bilayer, sterol and associated membrane proteins. Many drug molecules have 
intra-cellular targets. The alterations such species impose on membranes as they associate with and 
permeate these dynamic structures can have a profound influence on membrane structure, such as 
thickness, curvature, permeability and fluidity.4,5 And, can affect biological function including the 
integrity of the membrane barrier effect, cell signaling and adhesion, and thus in the toxicity of the drug.6–
9  For example, anesthetic molecules such as chloroform, halothane and diethyl ether have been shown to 
induce lateral expansion in the membrane, increasing local disorder in lipid tails adjacent to the 
intercalating anesthetic molecule.10 Similarly, amphotericin B, an antifungal agent, disrupts the fungal cell 
wall by making pores on the membrane that lead to cell death.11–13 Valinomycin and gramicidin A (gA) 
permeate the bilayer by forming ion channels that alter the membrane electrochemical resistivity.14–16 
Molecular lipophilicity is one of the key physicochemical properties considered predictive of 
passive molecular diffusion across the biological membrane17. Log P is one of the most commonly used 
reference systems for the assessment of molecular lipophilicity and prediction of permeability. Where P is 
the partition coefficient of a neutral molecule between an aqueous and lipophilic (usually octanol) phase. 
For ionized species the distribution coefficients, , the ratio of the sum of the concentrations of 𝐿𝑜𝑔𝐷
ionized and unionized forms of the compound in two phases is more appropriate.11 Though widely used in 
the pharmaceutical industry, these parameters are fairly crude predictors of membrane association and 
permeability that provide limited insight into the molecular nature of drug-membrane interaction. Indeed, 
recent evidence indicates that not only hydrophobicity but also lipid composition plays an important role 
in the passive diffusion of drugs across the lipid bilayer.4,18,19 
Artificial membranes offer a valuable means to study the interactions of drugs with the membrane 
during the earliest stages of drug development and can be used to anticipate both passive membrane 
permeability and membrane associated toxicological problems isolated from the complexity of the living 
cell.20 Also, where the molecular target is a membrane protein or where permeation is mediated through 
protein interaction, molecular insights into membrane-molecular interactions are important. Various 
biomimetic models such as liposomes and supported lipid bilayers (SLB) methods are widely used to 
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4interrogate the behavior of membrane lipids with small molecules. However, undulation of the membrane, 
limited stability, compositional versatility and means of interrogation are drawbacks attributed to 
unilamellar vesicles. Whilst, interference from the interfacial support on the fluidity and functionality of 
the bilayer and associated proteins in SLBs, are limitations to the application of these models in study of 
lateral diffusion of proteins and lipids in the membrane.21,22 Several modifications have been introduced 
to improve fluidity in supported membrane models, including tethered lipid bilayer membranes and 
cushioned bilayer membranes,23 but the lateral mobility of lipids and reconstituted proteins typically do 
not attain the mobility reported for giant unilamellar vesicles. Alternative approaches have emerged that 
assemble membranes supported over pores which can improve fluidity whilst maintaining stability.24–26 
We recently reported a microcavity supported lipid bilayer (MSLB) formed from polystyrene sphere 
templated polydimethylsiloxane (PDMS)27 for optical measurements and on gold-coated silicon wafers 
for electrochemical measurements. These platforms, because of their aqueous filled pore underlying the 
bilayer, combine the fluidity of a liposome with stability and versatility reminiscent of an SLB. These 
properties, along with their ease of interrogation by electrochemical and optical microscopy means and 
the deep aqueous reservoir below their proximal lipid leaflet make the MSLBs a versatile platform for 
interrogating molecular -membrane interactions at a lipid bilayer membrane in a robust, relatively quick 
and facile manner.  
Herein, using MSLB platforms, we examined the interactions of seven well-characterized drugs with 
biomembranes from three different families; non-steroidal anti-inflammatories; Ibuprofen (Ibu) and 
Diclofenac (Dic), antibiotics; Rifampicin (Rif), Levofloxacin (Levo) and Pefloxacin (Pef), and 
bisphosphonates; Alendronate (Ale) and Clodronate (Clo)., selected because they span different 
solubility,  and apparent permeability coefficients (Papp). The concentration of the drugs incident at 𝐿𝑜𝑔 𝑃
the microcavity supported lipid bilayer was systematically varied and fluorescence lifetime correlation 
spectroscopy (FLCS) was used to evaluate and compare the changes in the lateral mobility, fluorescence 
lifetime (τi) and molecular brightness (MB) of lipid probes in the membrane in response to drug 
concentration. In parallel, electrochemical impedance spectroscopy (EIS) was used to evaluate changes to 
membrane thickness and permeability as a function of drug concentration. Our data show significant and 
consistent changes on membrane interactions with drug type and provide new insights into drug-
membrane behavior.  The study indicates that the microcavity SLB platform is a useful and versatile 
interrogative tool for understanding and evaluating drug-lipid membrane using interactions.
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5Materials and Methods
Materials
1,2-Dioleyl-sn-glycerophosphocholine (DOPC), 1,2,-Dioleyl-sn-glycerophosphoethanolamine (DOPE), 
1,2,-Dioleyl-sn-glycerophosphoserine (DOPS), and 1,2,-Dioleyl-sn-glycerophosphoglycerol (DOPG) in 
powder form were purchased from Avanti polar lipids (Instruchemie, The Netherlands). Ibuprofen (Ibu), 
Diclofenac (Dic) sodium salt, Levofloxacin, Pefloxacin, Rifampicin, Alendronates, Clodronates and 
phosphate buffer saline (PBS) tablets were purchased from Sigma-Aldrich (Wicklow, Ireland), β-
BODIPY-C5-HPC ((2-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Pentanoyl)-1-
Hexadecanoyl-sn-Glycero-3-Phosphocholine) (530/550nm) was purchased from Thermofisher (Ireland) 
and DOPE-atto655 (ex. 650/em. 670nm) was purchased from Atto-tech GmbH (Siegen, Germany). All 
other chemicals were of HPLC grade from Sigma-Aldrich (Wicklow, Ireland), and were used as 
purchased. Ultrapure water with a resistivity  18.2 Mcm was produced by a MilliQ (Millipore 
Academic) system and used for buffer preparation. 
Vesicle preparation
The one component, binary and ternary lipid mixtures were prepared from DOPC, DOPC:DOPG (3:1), 
DOPC:DOPS (3:1), DOPC:DOPG:DOPE (2:1:1), [mol:mol]. For FLCS, lipids and fluorescent lipid probe 
(β-BODIPY-C5-HPC (BODIPY) and DOPE-Atto655 (ATTO)) were mixed in a ratio of 10000:1 mol/mol 
and dried under vacuum. The dried lipid films were rehydrated in 1 ml of 0.01 ᴍ phosphate buffer saline 
(PBS), pH 7.4 or 0.02 mᴍ Tris buffer, pH 5.25 and vortexed for a period of 30-60 s. Next, the lipid 
suspensions were extruded 11 times through a 100 nm polycarbonate filter using a mini-extruder (Avanti 
Polar Lipids) to form large unilamellar vesicles (LUV) that were then diluted to final concentration of 
0.25 mg/ml and stored at 4 C for further use. The vesicles were prepared in the same way but without the 
fluorescent probe for EIS measurements.
Microcavity array supported lipid bilayers
Lipid bilayers were suspended across aqueous filled microcavity arrays according to protocols modified 
slightly from previous reports.27,28 For fluorescence studies the microcavity arrays were made from 
polydimethylsiloxane (PDMS) [Sylgard 184 base and curing kit, Dow Corning]. Briefly, PDMS was cast 
onto a dried film of polystyrene spheres of 2.88 µm diameters, formed on freshly cleaved mica, and 
cured. The PDMS was peeled off the mica and the spheres were removed to form open spherical cavities 
embedded in PDMS. The planar PDMS was plasma cleaned, followed by 1 h of sonication in PBS buffer 
to ensure the cavities were filled with the aqueous solution.
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6Following aqueous filling, a combination of Langmuir-Blodgett (LB) and vesicle fusion (VF) methods 
were employed to fabricate MSLB. The details of Langmuir-Blodgett techniques are described in 
supplementary information. The microcavity for EIS measurements was made in an analogous way at 
gold-coated silicon wafers and the details are described in SI. 
Fluorescence Lifetime Correlation Spectroscopy (FLCS) 
FLCS experiments were performed using a Microtime 200 system (PicoQuant GmBH, Germany) 
consisting of FCS module, dual SPD detection unit, time-correlated single photon counting (TCSPC), and 
inverted microscope model Olympus X1-71 with a Olympus UPlan SApo 60x/1.2 water immersion 
objective. The lipid labeled fluorophores BODIPY and ATTO were excited using pulsed picosecond 
lasers at 532 nm laser PicoTA from Toptica (Picoquant) and 640 nm LDH-P-C-640B Picoquant, 
respectively. A single mode optical fiber guides the two lasers to the main unit and provides a 
homogeneous Gaussian profile for both excitations. The lasers were pulsed at 20 MHz, corresponding to 
an interval of 50 ns. The emitted fluorescence was collected through the microscope objective and 
dichroic mirror z532/635rpc blocked the backscattered light and HQ550lp AHF/Chroma for 532 nm and 
HQ670lp AHF/Chroma for 640 nm filters were used to clean up the signal. A 50 μm pinhole was used to 
confine the volume of detection in the axial direction. Fluorescence was detected using a single photon 
avalanche diode (SPAD) from MPD (Picoquant). The time-correlated single photon counting system 
(PicoHarp 300 from Picoquant), enabled simultaneous assessment of the lifetime in a nanosecond range 
along with the time of diffusion in the millisecond range.58 Using TCSPC allowed us to filter any 
contribution from after-pulsing, suppress scattered light and parasitic signals and background,30,31 and in 
parallel to calculate the fluorescence lifetime of the lipid probes in situ.
To calibrate the FCS confocal volume, Rhodamine 6G (532nm) and Atto655 (640nm) dyes with known 
diffusion coefficients were used.32 The volume was determined at the start of each set of experiments and 
at least 15 data points were collected from each sample and each data point was measured for 30 sec. The 
time-dependent fluctuations of the fluorescence intensity dI(t) were recorded and analyzed by an 
autocorrelation function G(t)= I + <dI(t´) dI(t´+ t)>/<I(t´)>2. As has been shown theoretically for an 
ensemble of m different types of freely diffusing species, G(t) has the following 2-dimensional analytical 
form:33
(1)
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7Here <N> is the average number of diffusing fluorescence species in the observation volume, fT and τT 
are the fractions and the decay time of the triplet state respectively, τDi is the diffusion time of the ith 
species, and α is the anomalous exponent respectively. α indicates the extent of deviation of diffusion 
coefficient (D) from Brownian behavior and it can vary between 0 to 2. A value of 1 indicates the free 
diffusion.34,35  The experimentally obtained G(t) is fit equation (1), to yield the diffusion time, τDi which is 
related to the diffusion coefficient D through D = r02/4τDi, where r0 is the lateral radius of the confocal 
volume. The fits of the autocorrelation curves were carried out using the PicoQuant software package 
using a least square Marquard-Levenberg algorithm. 
The fluorescent decays were fit to a multi-exponential model to obtain the luminescent lifetime, τi of the 
probe according to equation 2.36
  (2)𝐼(𝑡) =  ∑𝑛𝑖 = 1𝑎𝑖 𝑒𝑥𝑝( ―𝑡 𝜏𝑖)
where τi are the lifetimes with amplitudes ai. The values of τi and ai were determined using PicoQuant 
Symphotime software with nonlinear least-square fitting. 
The Molecular Brightness (MB) was calculated by dividing the average photon-counts per second by 
average number of molecules (N) computed from equation 1, given below37,38
   MB [counts per second per molecule] = <Average photon-counts>/ <N>
All measurements were performed at 20  0.4 C.
Electrochemical Impedance Spectroscopy, EIS.
EIS was performed with a CH660A potentiostat (CH Instruments, USA). A standard 3-electrode cell was 
employed which are comprised of an Ag/AgCl (1ᴍ KCl) reference electrode, a platinum wire auxiliary 
electrode and the gold microcavity array which constituted the working electrode. The EIS data were 
measured over a frequency range of 0.01 to 104 Hz with an ac modulation amplitude of 0.01 V at a 
potential bias of 0 V (vs Ag/AgCl). All measurements were carried out in a glass cell (approximate 
volume of 4 ml) in contact with electrolytes PBS buffer maintained at pH 7.4 or 20 mᴍ Tris buffer at pH 
5.25. The EIS of the aqueous filled microcavity array coated with the lipid bilayer was measured initially 
prior to addition of drugs to ensure signal stability. Subsequently, drug solutions were titrated into the 
glass cell containing buffer and the electrochemical impedance response of the lipid bilayer measured for 
each concentration. Each measurement takes approximately 10 min and were carried out at room 
temperature (20  0.4 C). The measured data were analyzed using Z-View software with the fitting 
model (Scheme 1) to determine the changes in membrane resistivity and conductance on drug interaction.
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8Equivalent circuit model for MSLB
Scheme 1: ECM model used to fit EIS data.
In order to extract the resistance and capacitance values for the MSLBs, the EIS data were fit to the 
equivalent circuit model (ECM) shown in scheme 1 which was described previously for the lipid bilayer 
modified microcavity array electrode.10 The circuit consists of the solution resistance (Rsol) in series with 
a resistor and a capacitor, which are in parallel and correspond to the electric and dielectric properties 
respectively of membrane deposited on the electrode surface (Rm, Cm). The ECM also contains an 
additional component to account for the resistance of the cavity array (Rarray), and the double layer 
capacitance (Cdl). The data for the bare cavities and those treated with MH were fitted with a 
Rsol(Rm||Cm), true constant as at this stage, as in the absence of the bilayer, the resistance and capacitance 
are expected to be uniform along the surface of the electrodes. A Constant Phase Element (CPE) is used 
in the equivalent circuit instead of pure capacitors to account for surface defects on both the electrode 
surface and the lipid bilayer. The impedance of a CPE is given by ZCPE = Q-1(jω)- where Q is the 
magnitude of the capacitance of the CPE, ω is the angular frequency, and  is a real number between 1 
and 0 (the closer  approaches 1, the more ideal the capacitive behavior of the CPE).
Langmuir and Langmuir-Freundlich Isotherms 
The EIS data for each drug were iteratively fit to non-linearized Langmuir and Langmuir-Freundlich 
isotherm expression as defined by Eq. (3) and (4) respectively;39
  (3)𝑅 =  𝑅𝑠𝑎𝑡(𝐾𝑎𝐶)1 + 𝐾𝑎𝐶
 (4)𝑅 =  𝑅𝑠𝑎𝑡(𝐾𝑎𝐶)𝑛1 + (𝐾𝑎𝐶)𝑛
where R is the change in membrane resistance, as function of bulk drug concentration, Rsat is absorption 
capacity that relates to the number of available binding sites, Ka is affinity constant for adsorption, C is 
the equilibrium concentration of the drugs and n (dimensionless) is the index of heterogeneity.
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9Results 
Figure 1 shows a schematic representation of the MSLB platform preparation used in this work For 
fluorescence measurements, a microsphere templating method reported previously27 was used to prepare 
PDMS microcavity arrays and is described in the methods section. The fluorescently labeled bilayers 
were suspended across the aqueous filled microcavity array by a combined LB-VF method, as illustrated 
in Fig. 1.  
Figure 1: A representation of MSLB platform preparation. (1) The polystyrene beads of diameter 2.88 
µm were drop cast either on a gold-coated silicon wafer for EIS or on mica for FLCS measurements, (2) 
Formation of microcavities on gold using electrodeposition method and on PDMS by a solidifying 
method. (3) Microcavities were filled with buffer and form a lipid monolayer using the Langmuir-
Blodgett technique. (4) Lipid vesicles, with fluorescent lipid probes for FLCS, were allowed to disrupt on 
the lipid monolayer to form the bilayer. Microcavity made on PDMS, turned into a small portable 
microfluidic device for FLCS measurement.
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Figure 2: Representative microcavity array formed on PDMS and gold substrate. (A) Reflectance image 
acquired from confocal microscopy, where the white spot represents an aqueous filled cavity and the 
black area corresponds to planar and unfilled cavities. (B) Fluorescent image of lipid bilayer labeled with 
DOPE-Atto655 spread across the microcavity array to form MSLB using the LB-VF method. (C) 
Scanning electron microscopy image of microcavity array formed on the gold substrate using the 
electrodeposition method. The scale bar was 10 m. 
The refractive index mismatch between PDMS (n  1.45) and the buffer (n  1.33) enables precise 
location of the pore suspended bilayers as the aqueous filled pores appear as intensely reflective spots in 
the white light back reflectance images as shown in Figures 2A and B. On locating the spanning bilayer, 
the observation volume is positioned at the center of a micropore and the bilayer located by z-scanning to 
find the most intense fluorescence point from where the autocorrelation function (ACF) trace is then 
collected. Time traces were, in all cases, acquired for 30 s and SymPhoTime 64 software was used to 
acquire and analyze the time traces. Representative ACF curves for labeled lipid diffusion in DOPC over 
a cavity are shown in Figure 3 (vide infra) along with their fit to the 2D-diffusion model (equation 1). The 
calculated diffusion coefficient of DOPE-ATTO655 in DOPC lipid membrane is 11.7 ± 0.47 µm2s-1 and 
that of β-BODIPY-C5-HPC, 14.20 ± 0.8 µm2s-1. These values are consistent with reported literature 
diffusion coefficient values for these probes at microcavity suspended bilayers as well as giant 
unilamellar vesicles (GUVs),27,40,41 and reflect the high degree of fluidity of the lipids supported across 
the aqueous filled micropores.
For EIS studies, the microcavities were prepared by polystyrene sphere templating and electrodeposition 
of gold onto gold-coated silicon wafers as reported previously 14,28 and the step by step protocol is also 
presented in experimental methods. Figure 2C shows a representative SEM image of the working area of 
the electrode. Such images confirm that the gold electro-deposition technique implemented produced 
uniform areas (1 cm2) of ordered closely packed 2.80 ± 0.04 μm microcavity arrays. The impedance of 
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the bilayer was monitored over 8 h to confirm that the impedance signal and thus the membrane is stable 
with no spontaneous changes to EIS signal observed during the experimental time window (cf. Fig. S1 
and Table S1, supplementary information (SI))
Drug-Membrane Interactions
NSAIDs: Ibuprofen and Diclofenac
The impact of Ibu on the fluidity of a DOPC lipid bilayer membrane was examined by systematically 
varying the concentration of Ibu from 1 µᴍ to 1 mᴍ. This concentration range was selected to encompass 
the reported therapeutic blood plasma levels of Ibu which lie in the range of 2 - 40 µᴍ with higher 
concentrations lying the range present in the gastrointestinal (GI) tract.42–44  Ibu in PBS buffer was 
injected into the flow chamber and allowed to equilibrate for 10 mins with the DOPC MSLB.  Control 
experiments where the equilibration times were extended over an hour confirmed no further changes to 
lipid mobility occurred beyond 10 mins.  To build statistical significance, ACFs were collected from 
between 20 and 30 different micropores across a single substrate. ATTO655-DOPE (ATTO) and β-
BODIPY-C5-HPC (BODIPY) were both used to probe the different aspects of the membrane 
environment. The ATTO is a cationic oxazine probe, which is relatively hydrophilic and conjugated to the 
lipid headgroup so resides at the aqueous interface of the lipid bilayer. Conversely, BODIPY is a 
hydrophobic probe, expected to orient relatively deeply into the hydrophobic core of the bilayer. These 
probes are well suited for FCS studies due to their high photostability and quantum yields.45 Figures 3A 
and B show representative ACF curves for ATTO and BODIPY lipid probes at DOPC MSLBs 
respectively following addition to 400 µᴍ of Ibu. The resulting data, following curve fitting to equation 
(1), is shown in the supplementary information (Table S2a,b, SI). FLCS enables us to simultaneously 
measure the fluorescence lifetime of the lipid probe along with FCS data. The molecular brightness (MB) 
of the lipid probe in the membrane as a function of Ibu concentration also was calculated. 
The diffusion coefficients of the ATTO probe across the different drug concentrations were, within 
experimental error, unaffected by bilayer exposure to Ibu (Table S2a, SI). The fluorescence lifetime of 
ATTO in the DOPC MSLB was 3.3 ± 0.02 ns with an MB of 6300 ± 600 counts per seconds per molecule 
(cpsm); both parameters were similarly unaffected by the presence of Ibu in the contacting medium. As 
expected, α values for diffusion of the lipid probe both in the absence and across all the concentrations of 
Ibu were 0.98 ± 0.02, reflecting Brownian diffusion of ATTO in DOPC membrane. 
The diffusion coefficient of BODIPY in the DOPC bilayer was found to be 14.20 ± 0.8 µm2s-1 and 
although only slightly dependent on Ibu concentrations, at the highest Ibu concentration (1000 µᴍ) D had 
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decreased to 12.40 ± 0.7 µm2s-1 (Table S2b, SI). The BODIPY probe exhibits faster diffusion than the 
ATTO. The fluorescence lifetime of BODIPY obtained in our studies is comparable to reported values in 
unilamellar vesicles and in methanol.30,46 The α value for this probe was 0.98 ± 0.01 consistent again with 
normal Brownian diffusion and similarly, no significant changes to diffusion modality were observed 
upon addition of Ibu to the contacting media. The fluorescent lifetime of the BODIPY probe was 5.94 ± 
0.08 ns for DOPC alone and this decreased modestly to 5.83 ± 0.03 ns when the bilayer was in contact 
with Ibu concentrations exceeding 100 µᴍ. The MB of BODIPY was unaffected by increasing 
concentrations of Ibu and measured as 12700 ± 1100 cpsm. Thus we conclude from FLCS that 
introduction of Ibu has modest impact on the fluidity or viscosity of the DOPC lipid membrane. 
Figure 3: Representative ACF data for (A) Ibuprofen BODIPY, (B) Ibuprofen ATTO, (C) Diclofenac 
BODIPY, (D) Diclofenac ATTO in DOPC lipid membrane on PDMS microcavity as a function of (□) 0 
and (○) 400 µᴍ of drug concentration. The lipid membrane suspended across the 2.88 µm cavity was 
filled with the PBS buffer, pH 7.4. 532 nm and 640 nm pulsed lasers were used to excite the BODIPY and 
ATTO molecules. 
Next, we studied the interaction of Dic with the DOPC lipid bilayer under the same conditions and 
concentrations used for Ibu, as their physiological concentrations are the same.47 Figures 3C and D show 
representative ACF data for DOPC MSLB labeled with BODIPY and ATTO lipid probes respectively 
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before and after 400 ᴍ Dic. Whereas, as reflected in Figures 3C and D, changes in the ACF data for the 
BODIPY labeled DOPC bilayer were modest, systematic concentration-dependent changes were observed 
for the ATTO labeled membrane. Tables 1 and S3 (SI) show the outcome of the fitting of FLCS data for 
ATTO and BODIPY labeled DOPC lipid membranes against the Dic concentrations. The D value of 
ATTO-DOPE in DOPC bilayer alone was 11.7 ± 0.47 µm2s-1 and this was unchanged at the lowest 
concentrations of Dic (1 and 4 µᴍ). However, D dramatically rises to 43.5 ± 4.7 µm2s-1 for 800 µᴍ and 
1000 µᴍ (Table 1). The number of molecules (N) in the observation volume was reduced from 3 for 
DOPC MSLB in the absence of Dic to 1 at higher concentrations of Dic (Table 1). Interestingly, the α 
value for ATTO was also influenced by Dic where it increased from  1 for DOPC bilayer alone/lower 
Dic concentrations to 1.21 ± 0.09 for concentrations of Dic exceeding 10 µᴍ. The fluorescence lifetime of 
ATTO in DOPC lipid bilayer was reduced from 3.3 ± 0.02 ns to 2.44 ± 0.06 ns with increasing 
concentration of Dic in the contacting solution. Similarly, MB of the ATTO in DOPC lipid bilayer was 
reduced from 6300 ± 600 cpsm in the absence of Dic to 1000 ± 100 cpsm for 1 mᴍ of Dic concentration 
in the contacting solution. At the end of the titration, the membrane contacting buffer was exchanged for 
fresh PBS buffer to remove the drugs from the contacting solution. Following this treatment the D value 
of ATTO reduced to 22.0 ± 2.0 µm2s-1  but did not fully recover, suggesting Dic irreversibly associated or 
permeates the membrane.
Table 1: FLCS determined parameters of ATTO lipid probes in the DOPC lipid membrane at designated 
doses of Dic in PBS buffer, pH 7.4.
Conc. (µᴍ) Mol. Brightness 
(X 1000)
Fluor. lifetime 
(ns)
Anomalous 
exponent α
N D (µm2/s)
0 6.3 ± 0.6 3.3 ± 0.02 0.98 ± 0.02 3.0 ± 0.5 11.7 ± 0.47
1 6.2 ± 0.5 3.3 ± 0.01 1.05 ± 0.02 2.5± 1 13.7 ± 0.3
4 6.1 ± 0.5 3.28 ± 0.01 1.0 ± 0.02 3.5 ± 0.5 11.9 ± 0.75
10 6.2 ± 0.4 3.24 ± 0.01 1.15 ± 0.02 2.0 ± 0.5 16.6 ± 0.8
40 5.0 ± 0.4 3.16 ± 0.01 1.08 ± 0.03 1.5 ± 0.5 18.0 ± 1.2
100 3.9 ± 0.5 3.04 ± 0.01 1.19 ± 0.04 1.0 ± 0.2 24.0 ± 2.4
400 1.6 ± 0.2 2.78 ± 0.04 1.21 ± 0.06 1.0 ± 0.4 34.3 ± 3.0
800 1.1 ± 0.1 2.5 ± 0.07 1.16 ± 0.5 1.0 ± 0.5 43.5 ± 4.7
1000 1.0 ± 0.1 2.44 ± 0.06 1.21 ± 0.09 1.5 ± 0.5 41.5 ± 5.0
After wash 6.0 ± 0.5 3.15 ± 0.02 1.14 ± 0.02 1.5 ± 0.5 22.0 ± 2.0
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As a control measure, we introduced Dic at random concentrations to the bilayer and subsequently 
removed the drug from the contacting solution and measured the changes using FLCS (Table S4, SI) to 
preclude the possibility that changes observed in the membrane are due to systematic damage to the 
bilayer caused by long exposure time to Dic. As shown in Table S4 (SI), the changes in the membrane 
dynamics either due to systematic titration of Dic or random addition of drug led to the same numerical 
values at each concentration point. This result indicates that Dic binds irreversibly to the membrane in a 
concentration-dependent manner where it impacts on the diffusion of ATTO which is oriented at the 
membrane aqueous interface. The behavior of the ATTO probe, its increasing diffusion coefficient and 
the anomalous exponent is similar to behavior observed when PEG was used to treat the DOPC bilayer.48 
We had attributed this behavior to the association of the ATTO probe with the bound interfacial PEG and 
its localization at the membrane interface. Here, the changes are only observed at concentrations of Dic 
exceeding 10 µᴍ. We speculate that the opposing charges at the ATTO and Dic adsorbed at the bilayer 
interface lead to electrostatic interactions between the two, leading to the association of the ATTO with 
the Dic at the bilayer interface.
We then examined the impact of Dic on BODIPY diffusion as this uncharged species orients within the 
bilayer core. The ACF fits for diffusion of BODIPY are tabulated in Table S3, SI. The diffusivity was 
observed to decrease slightly following the introduction of the drug, from 14.2 ± 0.8 µm2s-1 for the DOPC 
in the absence of Dic to an average D value of 12.27 ± 0.75 µm2s-1 for 1, 4, 10 and 40 µᴍ of Dic (Table 
S3, SI). Although this change was minimal relative to standard error, the mean trend was highly 
consistent across all replicates. The diffusivity decreased further to 11.44 ± 0.8 µm2s-1 at Dic 
concentrations exceeding 100 µᴍ. Unlike ATTO, the N and α values were unaffected by the presence of 
Dic, whereas the τi and MB of the BODIPY in DOPC lipid bilayer decreased upon increasing the 
concentration of Dic in the contacting solution (Table S3, SI). The lifetime of the BODIPY label within 
the bilayer was 5.94 ± 0.08 ns in the absence of Dic and systematically decreased with increasing Dic 
concentration to 4.12 ± 0.03 ns at 1 mᴍ Dic concentration. Correspondingly, the MB value of the probe 
decreased from 12700 ± 1100 cpsm for DOPC to 3400 ± 400 cpsm for 1 mᴍ Dic concentration. To 
exclude the possibility of Dic interaction with BODIPY that leads to the reduction of its lifetime ( ), we 𝜏𝑖
independently measured the  of BODIPY in chloroform : methanol (1:1) solution in the absence of 𝜏𝑖
bilayer. Upon introducing different concentrations of Dic upto 1mᴍ, no change in the lifetime of the 
probe was detected compare to the untreated solution (Table S5, SI) suggesting the change in  only 𝜏𝑖
occur in the membrane and not in solution. Taken together, the data indicate penetration of the Dic into 
the hydrophobic core of the membrane. The modification to florescence lifetime and molecular brightness 
indicate a change in the probes environment which can only occur if the Dic is penetrating the 
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hydrophobic core and suggests taken with the irreversibility of the response at the ATTO probe that Dic 
permeates the membrane. Finally, we introduced fresh PBS buffer to the MSLB to remove the drug from 
the contacting solution and acquired ACF data for the probe in the membrane. As observed for the ATTO 
labelled bilayer D, τi and MB only partly recovered indicating Dic remains bound, penetrating the 
hydrophobic core of the membrane (see after wash in Table S3, SI). 
EIS was then used to evaluate the impact of Ibu on changes in resistance and capacitance of lipid 
bilayer as this method is expected to be highly sensitive to ion permeation or modifications to bilayer 
packing or thickness if induced by the drug. The Ibu sodium salt in PBS buffer was introduced to the 
contacting solution of a DOPC bilayer on a gold microcavity, which functioned as the working electrode 
under the same conditions as described for the FLCS studies. The membrane resistance of the bilayer was 
evaluated prior to addition of the drug and found to be 5.56 ± 0.23 MΩcm2 (cf. Fig. S1 and Table S1, SI), 
which is consistent with the reported values for other SLBs based on either DOPC and/or different lipid 
compositions which are typically in the range of 0.1 to 4 MΩcm2,14,21,23,49–52 depending on the 
modification of electrode surface and surface area. 
The Ibu concentration was systematically increased from 1 µᴍ to 4 mᴍ, where the cavity was filled with 
PBS buffer at pH 7.4 (Table S6, SI).  Equilibration time was 10 mins after each concentration increase 
before EIS was measured, as before controls indicated no further change beyond this time interval.  Data 
were measured for each drug concentration in triplicate. There was no variation in response over these 
triplicate measurements again, confirming equilibrium between the drug and membrane occurred quickly. 
Each EIS measurement took 10 min to complete and the repeat measurement was taken directly after the 
preceding measurement. Then, after the highest concentration had been introduced, allowed to equilibrate, 
and EIS measured in triplicate, the lipid bilayer was washed through twice with PBS buffer to clear any 
remaining drug from the contacting solution. This was carried out to assess the reversibility of drug 
binding. In a separate EIS control experiment, we confirmed that exchanging the bilayer contact solution 
in this way had no measurable impact on the bilayer impedance. 
Figure 4A shows a representative Nyquist plot of the complex impedance data for a single DOPC lipid- 
MSLB with variable concentrations (0, 40, 400, 100 ᴍ) of Ibu. For a Nyquist plot, the sum of the real, 
Z, and imaginary, Z components represents the complex impedance (Fig. 4) which originates from the 
resistance and capacitance of the cell. An EIS data shifts towards Z (y-axis), indicates that there is an 
increase in the impedance of the bilayer. Similarly, a shift towards Z (x-axis) implies that the bilayer 
impedance is reduced. In lipid bilayer systems, reduced impedance (or admittance) is typically 
attributable to increased permeability or membrane ionic/aqueous leakiness,53 i.e. reduced electrochemical 
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resistance arising typically from changes to lipid packing or ion permeability. From visual inspection of 
the EIS curves, it is evident that Ibu causes a small but systematic decrease on bilayer impedance, as 
illustrated in Figure 4A. For quantitative insight, we extracted the resistance values of the lipid bilayer by 
fitting the EIS data to the equivalent circuit model (ECM) shown in Scheme 1. The relative change in 
resistance and capacitance values before and after drug addition, the data extracted from the fit results are 
summarized in Table 2. 
Figure 4: Nyquist plot titration of Ibu and Dic drugs into contacting solution at a DOPC bilayer 
suspended across 2.88 µm cavities in a 0.01 ᴍ PBS solution (pH 7.4): frequency range 0.01 Hz to 104 Hz 
with a bias potential of 0.0 V vs Ag/AgCl (1 ᴍ KCl). The ○, □, ◊, ∆ symbols represent DOPC lipid 
bilayer for 40 µᴍ, 400 µᴍ and 1 mᴍ concentration of (A) Ibuprofen and (B) Diclofenac in contacting 
solution.
It is evident, comparing the absolute resistance values from fitting across two substrates (Table S6, SI), 
that the initial resistance values vary from substrate to substrate. This is unsurprising, given the nature of 
the substrates, and is attributed to variations in the uniformity of cavity packing and consequent 
microscale roughness of gold substrate and surface coverage. Therefore, we compared data across several 
substrates and report the average relative changes in bilayer resistance and capacitance rather than 
absolute values as shown in Table 2. Ibu induces a modest but significant (by comparison with control, of 
a DOPC MSLB in absence of Ibu, Table S8, SI) and systematic decrease in bilayer resistance with 
increasing drug concentration. These changes were accompanied by small increases to the bilayer 
capacitance at higher drug concentrations. Together, the data indicate that the bilayer becomes more 
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permeable on Ibu interaction, which is attributed, from the modest change in capacitance, to decrease in 
membrane thickness indicating Ibu adsorption at the bilayer interface. 
FLCS data indicated that compared to Ibu, Dic elicits very significant changes in the DOPC lipid 
membrane fluidity affecting both probes oriented at the aqueous membrane interface and within the 
hydrophobic core. Figure 4B shows the impedance response at a gold supported DOPC MSLB at 
different concentrations of Dic (0, 40, 400 and 1000µᴍ). From visual inspection of the EIS response 
shown in Figure 4B, it is evident, and consistent with the FLCS data that Dic interacts in a more intimate 
way with the bilayer than Ibu. In contrast to Ibu, impedance decreases with increasing concentration of 
Dic at the DOPC membrane. Furthermore, the magnitudes of the relative change in impedance are 
significantly greater and evident even at the lowest concentration of Dic (1 µᴍ). Removal of Dic from the 
contacting solution at the end of the titration left the impedance spectra relatively unchanged. This 
observation is consistent with FLCS data indicating the drug associates strongly, penetrates deeply and 
irreversibly into the phosphatidylcholine membrane.5
The resistance and capacitance data for Dic are summarized in Table 2. The data shown were collected 
from three independently prepared and studied gold cavity array substrates. As a control, the stability of 
bilayer at an intermediate Dic concentration of 100 µM was monitored and it was observed that no 
significant changes to the bilayer resistivity over 3-4 hrs (Fig. S2 and Table S7, SI). As Dic was prepared 
in a minimum volume of methanol to aid solubility, a control was conducted to ensure that the membrane 
resistance change was not due to membrane disruption by methanol (Figures S3, S4 and Table S9, SI). 
The impact of methanol at the concentration of 0.1% V/V used here, was insignificant compared with the 
impact of Dic, confirming that the change in resistance is due to Dic. 
EIS shows that both Ibu and Dic induce systematic decreases in membrane resistance with increasing 
drug concentration. Consistent with FCS data, the magnitude of resistance change is far greater for Dic 
than Ibu indicating the former is impacting the lateral packing density of the membrane and significantly 
increasing its ion permeability. We did not observe a significant difference between the capacitance 
changes of the bilayer between Ibu and Dic, suggesting that the layer thickness in each case is comparable 
and only modestly affected by these drugs (Table 2).
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Table 2: Effect of Ibu and Dic on the resistance and capacitance of DOPC bilayer at increasing 
concentrations. Results depict change (Δ) recorded following drug addition, relative to bilayer prior to 
drug interaction.
Ibuprofen DiclofenacConcentration (µᴍ)
∆Rm (MΩcm2) ∆Cm (µFcm-2) ∆Rm (MΩcm2) ∆Cm (µFcm-2)
DOPC 0.00 0.00 0.00 0.00
1 -0.07 ± 0.06 0.00 0.98 ± 0.07 0.00
5 -0.30 ± 0.04 0.02 ± 0.02 -1.35 ± 0.13 0.03 ± 0.01
20 -0.39 ± 0.17 0.04 ± 0.03 -1.75 ± 0.20 0.05 ± 0.02
40 -0.51 ± 0.25 0.07 ± 0.04 -2.08 ± 0.32 0.05 ± 0.05
100 -0.72 ± 0.31 0.14 ± 0.03 -2.55 ± 0.50 0.18 ± 0.09
400 -0.72 ± 0.39 0.18 ± 0.05 -3.68 ± 0.56 0.25 ± 0.04
1000 -0.76 ± 0.46 0.25 ± 0.03 -3.64 ± 0.49 0.24 ± 0.08
Antibiotics: Rifampicin, Levofloxacin and Pefloxacin.
We examined three antibiotics, Rifampicin, and two synthetic fluoroquinolone antibiotics Levofloxacin 
and Pefloxacin. The impact of Rif on the fluidity of a DOPC lipid membrane was examined by varying 
the concentration of Rif from 1 - 20 µᴍ. The experiments were performed, as described for Ibu and Dic 
and representative ACF curves are provided in the supplementary information (Figure S5A, SI). The data 
were fitted to a 2D-diffusion model and results are summarized in Table 3a,b. A complication in 
interrogating the Rif is that has a visible absorbance between 400 – 600 nm (Figure S6, SI) and at 
concentrations in excess of 20 µM, this feature masks the fluorescence signal from the probe resulting in 
rather noisy ACF data and very low molecular brightness for lipid probes.  
With increasing concentration of Rif, D of ATTO increased dramatically to 209.5 ± 34.3 µm2s-1 for 20 µᴍ 
of drug (Table 3a). The α value for ATTO was also influenced by Rif and increased to 1.13 ± 0.14 at this 
concentration. The fluorescence lifetime and molecular brightness of ATTO in DOPC lipid bilayer were 
reduced from 3.3 ± 0.02 ns to 2.99 ± 0.04 ns and 6300 ± 600 cpsm to 1000 ± 100 cpsm with increasing 
concentration of Rif in the contacting solution. At the end of the titration, the membrane contacting buffer 
was exchanged for fresh PBS buffer to remove the drugs from the solution. Following this treatment, D of 
ATTO was 20.8 ± 5.2 µm2s-1 and did not fully recover suggesting the Rif irreversibly 
associates/permeates with the membrane. Rif impacted the fluorescence correlation data for the DOPC 
membrane in an analogous way to Dic but the concentration of 20 µᴍ at which the effect was observed 
was much lower for Rif. 
Page 18 of 36
ACS Paragon Plus Environment
Langmuir
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
19
To examine the impact of Rif on BODIPY diffusion, we studied 0.01, 0.1, 1 and 5 µᴍ of Rif 
concentrations. At concentrations exceeding 5 µᴍ, no ACF data were obtained and molecular brightness 
was very low due to the strong absorbance of Rif drug (data not shown). Table 3b shows diffusion data 
for BODIPY in DOPC membrane as a function of concentration of Rif. On increasing the concentration 
of the drug, D decreased to 6.38 ± 1.5 µm2s-1 and α was reduced to 0.83 ± 0.04 for 5 µᴍ. Similarly, the 
lifetime and molecular brightness of the BODIPY label within the bilayer decreased to 4.82 ± 0.18 ns and 
4500 ± 1004 cpsm for 5 µM. The alteration to diffusion coefficient and probe lifetime indicates the drug 
impacts the probe environment which can only occur if Rif is penetrating into the hydrophobic core. 
However, measured molecular brightness changes may be due to the filtering of the excitation signal by 
Rif. On replacing the drug solution with fresh buffer in the microfluidic chamber the D, τi and MB values 
of the probe in the membrane are only partly recovered indicating Rif partitions strongly into the 
hydrophobic core of the membrane and is permeating the membrane (Table 3b). 
Analogous FCS studies of Levo and Pef, in contact with DOPC MSLB, were carried out and the data are 
shown in Tables S10A and B (SI). The concentrations used in this study correspond to the reported 
plasma level which is in the range of 10 µᴍ54. Notably, unlike Rif, neither Levofloxacin nor Pefloxacin 
exerted any significant impact on the D value of ATTO in DOPC membrane (Figure S7, SI). Similarly, 
the mobility of BODIPY probes in DOPC lipid membrane was not affected by the presence of 20 µᴍ 
Levo and Pef in contacting solution (Table S11 SI), τi, MB, and α values for both probes also were 
unaffected by the presence of Levo and Pef. 
Table 3: FLCS data analysis of ATTO and BODIPY in microcavity supported DOPC lipid bilayer as a 
function of Rif concentration
a) ATTO
Conc. (µᴍ) Mol. Brightness   
(X 1000) cpsm
Fluor. lifetime 
(ns)
Anomalous 
exponent α
D (µm2s-1)
0 6.20 ± 0.9 3.30 ± 0.03 0.98 ± 0.03 11.71 ± 0.82
1 4.20 ± 0.3 3.21 ± 0.05 1.06 ± 0.09 19.58 ± 2.09
5 5.3 ± 0.3 3.27 ± 0.01 0.95 ± 0.03 48.83 ± 2.80
10 2.5 ± 0.3 3.10 ± 0.04 1.16 ± 0.08 125.7 ± 18.3
20 2.0 ± 0.2 2.99 ± 0.04 1.13 ± 0.14 209.5 ± 34.3
After wash 4.15 ± 0.9 3.10 ± 0.05 0.75 ± 0.12 20.8 ± 5.2
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b) β-BODIPY-C5-HPC
Conc. (µᴍ) Mol. Brightness   
(X 1000) cpsm
Fluor. lifetime 
(ns)
Anomalous 
exponent α
D (µm2s-1)
0 12.45 ± 2.40 6.0 ± 0.1 0.95 ± 0.03 11.52 ± 1.20
0.01 12.81 ± 2.75 6.03 ± 0.09 0.97 ± 0.02 11.23 ± 0.74
0.1 10.20 ± 2.00 5.77 ± 0.26 0.93 ± 0.02 9.31 ± 0.56
1 6.50 ± 1.75 5.25 ± 0.16 0.82 ± 0.05 6.97 ± 1.14
5 4.50 ± 1.04 4.82 ± 0.14 0.83 ± 0.04 6.38 ± 1.50
After wash 9.58 ± 2.45 5.87 ± 0.13 0.93 ± 0.05 9.76 ± 1.23
Representative Nyquist plots for Rif (Fig. S8, SI), Levo and Pef (Figs. S9A and B) drugs on interaction 
with DOPC membrane at gold microcavity SLB are provided in supplementary information. The 
membrane resistance was observed to decrease with increasing drug concentration, across all of the 
antibiotics, but consistent with FCS, the effect was most pronounced for Rif and moderate for Levo and 
Pef. (Table 4). Similarly, the capacitance was increased in the presence of Rif, modestly increased for 
Levo and Pef did not measurably affect membrane capacitance (cf. Table 4). Given the inverse 
relationship between capacitance and the thickness of the dielectric, this response indicates the membrane 
becomes thinner in the presence of Rif. The direction and magnitude of the changes in the resistance data 
correlated well with changes in the diffusion coefficient observed for each drug. 
Table 4: Effect of Rif, Levo and Pef on the resistance and capacitance of a DOPC lipid bilayer with 
increasing concentration. Results presented depict the change () recorded following drug addition, 
relative to bilayer prior to drug interaction.
Rifampicin Levofloxacin Pefloxacin[Drug] 
(µᴍ) ∆Rm 
(MΩcm2)
∆Cm
(µFcm-2)
∆Rm
(MΩcm2)
∆Cm
(µFcm-2)
∆Rm 
(MΩcm2)
∆Cm
(µFcm-2)
0 0 0 0 0 0 0
1 -0.210.02 0.050.001 -0.010.03 0.150.01 -0.060.02 0.080.001
5 -1.740.04 0.270.004 -0.110.02 0.230.01 -0.070.04 0.090.004
10 -4.1190.03 0.470.08 -0.140.01 0.340.02 -0.0820.03 -0.100.007
20 -4.3650.02 0.970.01 -0.210.01 0.400.01 -0.120.01 -0.120.06
Interaction of Rifampicin with different lipid compositions
Given the evidence for permeation of the Rifampicin into the bilayer, we studied the interaction of Rif 
with different lipid compositions representative of bacterial membranes. Here, we used lipid mixtures 
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made from phosphatidylglycerol (PG), phosphatidylethanolamine (PE) and phosphatidylserine (PS).  (PG 
and PE are the most prevalent lipids in bacterial membrane55–57 and PS is anionic lipid from the 
mammalian membrane55) so that we could compare the impact of the anionic charge on the lipid, for PS 
and PG on drug interactions. These experiments were carried out as described for Rif interaction with 
DOPC lipid membrane, varying the concentration of Rif from 1 - 20 µᴍ.  Representative ACF data and 
analysis are provided as supplementary information (Figure S5 and Tables S12-S14, SI). 
We examined Rif interaction at MSLBs with 3 different lipid compositions: DOPC:DOPG (4:1), 
DOPC:DOPS (4:1) and DOPC:DOPG:DOPE (3:1:1) (mole ratio). The D value of ATTO in all lipid 
mixtures increased with increasing concentration of drug, consistent with the data observed for pristine 
DOPC bilayer. However, by 20 µᴍ Rif addition, D was found to be 52.60 ± 6.8 µm2s-1 (Tables S12-S14, 
SI), which was approximately 4 times less than observed at the DOPC only bilayer. Figure 5 describes the 
relative change in lipid diffusion for a given concentration of Rif against the lipid diffusion without drugs 
for lipid mixtures. The impact of Rif was similar across all lipid compositions with no significant 
variation between DOPG and DOPS. The α value for ATTO in all the lipid mixtures was greater than 1 at 
20 µᴍ like behavior in a DOPC bilayer. Similarly, the fluorescence lifetime and molecular brightness of 
ATTO in DOPC:DOPG, DOPC:DOPS, DOPC:DOPG:DOPE was reduced on increasing the 
concentration of Rif, indicating the drug is disrupting the interfacial region of the bilayer, however the 
effect is dramatically reduced in the presence of anionic phospholipid. On conclusion of the titration, the 
membrane contacting buffer was exchanged for fresh PBS buffer and D value of ATTO was close to that 
found on exposure to 1 µᴍ Rif indicating some Rif remains associated with the membrane (Tables S12-
S14, SI).
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Figure 5: Change in diffusion coefficient (∆D = D-D0) of Rifampicin in designated lipid mixtures: 
DOPC: DOPS [4:1] (○, black), DOPC: DOPG [4:1] (∆, red), DOPC:DOPG:DOPE [3:1:1] (◊, blue), 
DOPC (□, olive). The D value was measured as a function of concentration of drug on lipid the 
composition described above using FLCS and bilayer was spread across the microcavity supported lipid 
bilayer.
Analogous EIS experiments were then completed to evaluate changes to membrane thickness and 
permeability. The changes in the resistance and capacitance for all the lipid compositions in the presence 
of Rif are summarized in Table 5. For all lipid compositions, membrane resistance decreased with 
increasing concentration of Rif (Fig. S10, SI). However consistent with the FLCS data, the magnitude of 
the resistance decrease is 4 times lower compared the DOPC-only membrane (Table 3). Notably, the 
magnitude of the decrease in bilayer resistance is far greater in the presence of DOPG compared to DOPS 
lipids. For example, at the highest concentration of Rif explored, 20 ᴍ, the resistance had decreased on 
average by 1.63 Mcm2 for a DOPC:DOPS(4:1) MSLB composition compared to 2.49 Mcm2 and 4.65 
Mcm2 for DOPC:DOPG(4:1) and DOPC:DOPG:DOPE(3:1:1) respectively. This indicates that although 
both DOPG and DOPS are acidic lipids (anionic at neutral pH) Rif interacts significantly more strongly 
with DOPG. Although by far the strongest perturbation of the bilayer is evident for the neutral DOPC-
only bilayer. Clearly charge influences Rif interaction with the membrane, Rif is a neutral species at 
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physiological pH, it is zwitterionic and is both a H-bond donor and acceptor and such interactions likely 
inhibit penetration of the drug into charged bilayers.
Table 5: Resistance data for different lipid mixtures as a function of concentration of Rif. Results 
presented reflect the change (Δ) recorded following drug addition, relative to bilayer prior to drug 
interaction.
DOPC:DOPG(4:1) DOPC:DOPS(4:1) DOPC:DOPG:DOPE(3:1:1)[Rif] 
(µᴍ) ∆Rm
(MΩcm2)
∆Cm 
(µFcm-2)
∆Rm 
(MΩcm2)
∆Cm 
(µFcm-2)
∆Rm 
(MΩcm2)
∆Cm 
(µFcm-2)
0 0.00 0.00 0.00 0.00 0.00 0.00
1 -0.65 ± 0.08 -0.02± 0.03 -0.29 ± 
0.05
0.01± 0.005 -1.88 ± 0.09 -0.03± 0.01
5 -1.09 ± 0.06 -0.02± 0.01 -0.77 ± 
0.14
0.04± 0.02 -2.67 ± 0.41 0.00± 0.02
10 -1.83 ± 0.20 -0.09± 0.01 -1.34 ± 
0.09
0.05± 0.03 -3.92 ± 0.35 0.02 ± 0.03
20 -2.49 ± 0.47 -0.13± 0.05 -1.63 ± 
0.16
0.03± 0.01 -4.65 ± 0.23 0.03± 0.03
Notably, in the presence of anionic lipid, the impact of Rif on membrane capacitance is 
negligible when compared with DOPC only bilayer. It is also interesting to note that among the 
three mixed bilayer compositions, the magnitude of change in capacitance is greater for 
DOPC:DOPG bilayer than DOPC:DOPS and DOPC:DOPG:DOPE bilayers. 
Bisphosphonates: Alendronate and Clodronate
Finally, we studied the interaction of membrane impermeable bisphosphonate drugs, Alendronate and 
Clodronate with the DOPC membrane. Bisphosphonates are acidic and thus we carried out the study at 
pH 5.25. The Langmuir-Blodgett trough and microcavities were filled with Tris buffer, pH 5.25, 137 mᴍ 
NaCl, and DOPC lipids were transferred from subphase to form monolayers above the cavities. The 
DOPC vesicles were prepared using the same buffer and allowed to disrupt above the lipid monolayer to 
form a bilayer. Otherwise, the experimental setup and procedure were identical to those above. The drugs 
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were dissolved in the Tris buffer and pH was adjusted to match that of the whole system (pH 5.25). From 
FCS, the D value of ATTO in DOPC lipid membrane was 11.00 ± 0.8 µm2s-1 for  Tris buffer, pH 5.25, 
and as expected is consistent with the value calculated in contact with PBS buffer, pH 7.4. The 
concentration of drug was increased from 1 to 4 mᴍ in 1 mᴍ step and the D value of ATTO probe was 
measured at each concentration. Neither Alen nor Clo, induced a change in the D, α, τ and MB in DOPC 
lipid membrane (Table S15, SI). Furthermore, we studied BODIPY in DOPC lipid membrane at a drug 
concentration of 4 mᴍ and for both the drugs (Table S16, SI), again no notable changes were observed for 
D, α, τ and MB indicating the absence of any permeation of drugs across the lipid bilayer.
The interaction of bisphosphonate with a DOPC membrane in Tris buffer, pH 5.25 was studied 
using EIS. The stability of the bilayer at this pH was first examined by EIS (Figure S11, SI). The constant 
impedance indicated the DOPC bilayer was stable over the 5 hour window required for the measurement. 
Then, we systematically introduce the bisphosphonate drugs into the contacting medium and measured 
EIS as described above. In the case of Alen, no significant changes were observed in membrane 
resistance, but the small reduction in the capacitance suggested some adsorption of Alen on the DOPC 
membrane surface. The resistance and capacitance values remain invariable upon interaction with Clo 
over the concentration range of 1-4 mᴍ (Table 6). 
Table 6: Resistance and capacitance changes as a function of the concentration of Alen and Clo. Results 
reflect the change (Δ) following drug addition, relative to bilayer prior to drug interaction.
Alendronates Clodronates[Drug] 
(mM) ∆Rm 
(MΩcm2)
∆Cm
(µFcm-2)
∆Rm
(MΩcm2)
∆Cm
(µFcm-2)
0 0 0 0 0
1 -0.24  0.05 -0.75  0.4 0.13  0.8 -0.02 0.01
2 -0.05  0.05 2.0  0.5 0.19  0.4 0.02  0.02
4 -0.25  0.15 2.01  0.7 0.29  0.15 0.03  0.02
Discussion
There are two mechanisms that have been ascribed to molecular permeation across a pure lipid 
membrane; the solubility-diffusion (SD) and the transient-pore (TP) mechanisms58. In SD, the drug is said 
to partition into the lipid membrane, diffuse through the core and then partition into solution. In the TP 
mechanism, transient pores instigated by thermal fluctuations of the membrane are thought to promote 
permeation59. In both cases, the adsorption of the drug at the membrane interface precedes permeation. 
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EIS is expected to be sensitive to these processes, where porosity is increasing, resistance decreases and 
capacitance can increase due to thinning of the bilayer. Where adsorption is occurring without 
permeation, the capacitance may increase without accompanying changes to membrane resistance or 
fluidity. 
From EIS data it is clear that the bilayer resistance (R) increases with drug concentration reaches 
saturation (Tables 2 and 4); the resulting curves as shown in Figure 6, can be fitted using Langmuir-
Freundlich (LF) model.
Figure 6: EIS data fitted to non-linear Langmuir-Freundlich (solid line) Isotherms for different drugs, A: 
Dic and Ibu, and B: Levo, Pef and Rif using Eqn. (4). ∆R correspond the change in membrane resistance 
after drug addition compared to membrane alone. 
Like EIS studies, the relative change in lipid diffusion coefficient of ATTO probe as a function of drug 
concentration for both Ibu and Dic at the MSLB (Figure S12, SI) also exhibited a sigmoidal response, 
suggesting saturation binding. However, the modest impact of Ibu on membrane fluidity meant that a 
reliable binding curve could not be obtained from FLCS data for this drug. Nonetheless, from the EIS 
data shown in Figure 6A, the plateau regions (saturation binding) occur at approximately 400 ᴍ for Dic 
and 100 ᴍ for Ibu. Such a dependence of drug concentration on the physical characteristics of the 
membrane could be attributed to membrane binding and thus Langmuir-Freundlich isotherm was used to 
describe the adsorption of the drug onto the DOPC MSLB. On this basis, Rsat and a binding constant, Ka 
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were estimated by non-linear regression analysis and values are summarized in Table 7 along with the 
reported clogP and Papp values for each drug60. 
From the data shown in Fig. 6A and B, we observed good fit (R2 > 0.97, cf. Table 7) to LF isotherms for 
all of the drugs explored. The calculated values, of course, are not absolute and will depend on 
experimental conditions such as membrane area. Nonetheless, for drugs at a given bilayer platform these 
parameters are a useful empirical measure of the impact of each drug on the lipid bilayer. With the 
exception of Ibuprofen the Rsat values correlate reasonably well with both Papp and cLogP.  Ka values 
conversely do not correlate with these parameters. For example, Rsat is similar for Ibu and Rif and they 
are the two most lipophilic of the drugs investigated. Nonethless Ka calculated from the fits as 1.82 x105 
ᴍ1 for Rif compared with 0.09 x105 ᴍ1 for Dic.  Because the drugs are not merely adsorbing at the 
membrane the low Ka value for Dic from the LF model is tentatively attributed to the high penetration 
into and passive permeation of this drug across the membrane whereas Rif may be retained more strongly 
at the membrane.  
Table 7: Association constants calculated for drugs by fitting relative change in DOPC membrane to non-
linear Langmuir-Freundlich isotherm model. The clogP and Papp parameters are literature reported values. 
Drug clogP61 Ka (x105) Rsat n R2 Papp (x 10-6 cm/sec)a
Ibuprofen 3.679 0.780.18 0.810.02 0.74 0.97 10.1 ± 0.262
Diclofenac 4.726 0.090.1 5.421.9 0.33 0.97 13.28 ± 0.263
Rifampicin 2.77 1.820.08 4.380.15 4.55 0.99 5.0 ± 0.2064
Levofloxicin -0.879 0.950.2 0.310.08 1.1 0.96 0.26 ± 0.005~65
Pefloxicin 0.27 5.32.3 0.090.01 1.2 0.99
Alendronate -5.642 -- --
Clodronate -2.40 -- -- 0.05 ± 0.00266
        aapparent permeability coefficient of drugs in Caco-2 cells; ~ Egg-Phosphatidylcholine lipids
EIS and FLCS data indicate Ibu interaction with the DOPC bilayer at pH 7.4 is confined to weak 
interactions at the interface of the bilayer which do not affect lipid lateral mobility. Several studies on 
interaction Ibu with phosphocholine bilayers show the fluidity of the membrane was unaltered leading to 
the conclusion that the drug resides close to the head group through non-covalent interaction with 
lipids.5,67–69,69 Consistent with this picture, our data suggest surface binding of the ibuprofen to the bilayer, 
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most likely through electrostatic interaction between the quaternary ammonium part of choline head 
group and the anionic Ibu. This finding contrasts with in vivo studies on cell lines which clearly show Ibu 
transports across the cell membrane. The Papp values of ibuprofen in different cell lines including Caco-2 
cells are > 10 x 10-6 cm/s consistent with high absorption/permeability across the membrane.62,63,70. 
Interestingly, Novakova et. al, found the transport of Ibu was reduced significantly in the absence of 
serum and Ibu strongly binds to serum.70  Overall, the strong consistency of evidence across model 
studies and the contrast between biophysical model and cells is consistent with active transport of Ibu 
within cells mediated by plasma or extracellular proteins and that passive transport is likely to be weak. 
In the case of Dic,  numerous biophysical studies have demonstrated that this compound exerts a strong 
interaction with the membrane core. 3171 72 From our data, the decrease in fluorescence lifetime and 
increase in diffusion coefficient suggests that the ATTO probe itself interacts strongly with the Dic bound 
at the interface, possibly lifting the probe from the membrane 
However, τi and MB of the BODIPY probe decreased which is strongly suggestive of drug permeation 
through the membrane. The lateral mobility of the hydrophobic probe was reduced in the presence of Dic, 
indicating a change in the fluidity of the membrane, whilst the anomalous exponent was unchanged, 
indicating normal diffusion. 
The calculated Ka value for Dic is low compared to Ibu (Table 7) and reported Papp for Dic in different 
cell lines is > 10 x 10-6 cm/s suggesting that the drug strongly adsorbs and permeates across the 
membrane. Overall, our results, combined with reported cell uptake data suggest that whereas Ibu is likely 
primarily transported through membranes via an active mechanism, Dic is likely to be strongly passively 
transported across cell membranes. Importantly, membrane capacitance changes were positive and of 
similar magnitude for both drugs indicating a modest decrease in membrane thickness. However, in each 
case the membrane integrity is preserved on drug binding, consistent with low membrane toxicity. 
Similarly, Langmuir-Freundlich isotherm applied to membrane resistivity for Rif yielded an excellent fit 
with a R2  0.99. The “n” constant in the LF model (Eq. 4) relates to the strength of the adsorption. The n 
1 observed here indicates chemically mediated absorption, n =1 suggests a linear relationship between 
the quantity absorbed and the equilibrium drug concentration and n > 1 indicates slightly unfavorable 
absorption. In our case, n = 4.33 (Table 7) suggesting a highly unfavorable process due to competition 
with water for absorption sites or more likely due to permeation across the membrane73. In agreement 
with EIS, our FLCS studies, revealed fast diffusion of DOPE labeled with an ATTO probe, along with a 
significant reduction in the fluorescence lifetime and molecular brightness indicating the association of 
Rif with the headgroup of the bilayer. In contrast to ATTO, the BODIPY probe, which is located in the 
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hydrophobic core of the bilayer, exhibits reduced diffusion for Rif concentrations exceeding 5 µᴍ with 
accompanying reductions in τT and MB. This indicates that Rif permeates the core, passively diffusing 
across the bilayer. Our results are consistent with a previous study by Rodrigues et al. based on 
fluorescence quenching of probes located at the surface and an inner core of a DPPC bilayer74. The 
similar quenching efficiency for both probes suggested Rif permeates the membrane core.75 
Both FLCS and EIS data reflect similar differences between Rif and DOPC-only membrane and 
membranes containing negatively charged lipids. From EIS data the change in membrane resistivity was 
plotted against Rif concentration for various lipid compositions and data were fitted to the Langmuir-
Freundlich model (Figure 6B and Figure S13, SI) to give a calculated association constant Ka = 1.8 x 105 
ᴍ1 for DOPC lipids (Table 7) and 0.19 x 105 ᴍ1 for a membrane containing DOPG lipids (Table S17, 
SI). The distinction is comparable to partition coefficients (Kp) determined for Rif with DMPC liposomes 
( 5.09 x 104) and DOPG liposomes ( 0.54 x 104).74 Recent isothermal titration calorimetry studies on 
POPC and ternary lipid mixtures POPE/POPC/POPG gave Kp = 1.9 x 103 for POPC and 8 x 101 for a 
ternary lipids membrane in the presence of Rif.56 These data clearly indicate that Rif interacts specifically 
with PC and PG lipids. Consistent with this report, we obtained a different association constant for Rif in 
these lipid compositions (Table 7 and Table S17, SI). For DOPE:DOPG:DOPC, Ka was obtained as 0.77 
x 105 ᴍ1 which is lower than DOPC aloneand consistent with data reported for liposomes.56 As Rif is 
zwitterionic at physiological pH (7.4) with 40% in the anionic form.  The lower affinity of Rif for 
DOPC:DOPG:DOPE (representative of a bacterial membrane) maybe attributed in part to repulsion 
between the ionized Rif and negatively charged lipids. In addition, high lateral packing of the membrane 
due to the presence of phosphatidylethanolamine and phosphatidylglycerol /phosphatidylserine may also 
reduce the permeability of the drug in such membranes. In particular, lipid-lipid spacing decreases in the 
presence of PE lipids, due to additional hydrogen bonds with neighboring molecules through the amine 
headgroup.76,77 
For Rif at a DOPS enriched lipid membrane, the lateral mobility of ATTO was the same as for DOPG 
enriched membranes. However, the relative change in membrane resistivity was different, as detected by 
the EIS technique which is more sensitive to changes in membrane structure than FCS. The relative 
change was -1.63 ± 0.16 MΩcm2 for the DOPS membrane compared to -2.49 ± 0.47 MΩcm2 for the 
DOPG membrane and both can be fitted to the LF model with R2 = 0.99. The significant difference in the 
affinity of Rif with the charged lipids cannot be explained solely by charge repulsion. 
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In contrast to Rif, change in the membrane resistivity for Levo can be fitted to a Langmuir Isotherm with 
R2 > 0.99 suggesting that this drug adsorbs onto the DOPC membrane interface. Although we observed a 
moderate increase in the membrane capacitance, the lateral mobility of ATTO and BODIPY in the DOPC 
membrane was relatively unchanged. Conversely, for Pef, we did not observe a significant change in 
resistivity or capacitance. Langmuir isotherm fit yielded R2 > 0.90 indicating minimal absorption on the 
membrane. Similarly, diffusivity of ATTO and BODIPY was relatively unchanged. The reported Papp 
value for Levo in Caco-2 cells is < 1 x 10-6 cm/s which is considered poor absorption. It has been 
proposed that these drugs are transported in membranes through an active mechanism by transporter 
proteins78–80 rather than by passive diffusion, which is consistent with our study.
Finally, the bisphosphonate drugs studied on DOPC MSLBs had a very little impact on the fluorescence 
or electrochemical properties of the films. The diffusivity of ATTO and BODIPY probes in a DOPC 
membrane was unaltered in the presence of the drugs. Similarly, no change in the membrane resistivity 
was observed for Alendronate and only a slight increase was observed for Clodronate at a concentration 
of 4mᴍ. Conversely, an increase in membrane capacitance was observed with Alen for concentrations 2 
mᴍ which may suggest that the film thickness has decreased. This is tentatively attributed to adsorption of 
the drugs at the membrane interface, at higher concentrations. The low Papp and high hydrophilicity 
indicate that these drugs are poorly permeable to the membrane and they are believed to be transported 
across the membrane through a paracellular route66,81. Our data support these conclusions. 
Conclusions: Using FLCS and EIS along with microcavity supported lipid bilayer membranes we 
compare for the first time the impact that commonly administered anti-inflammatory, antibiotic and 
bisphosphonate drugs have on lipid membrane fluidity and electrochemical properties. 
Upon systematically varying the concentration of drugs over therapeutic ranges, we measure the lipid 
membrane diffusion coefficient along with the fluorescence lifetime (τi) and molecular brightness (MB) 
of the lipid probe using FLCS. In parallel, we investigated the changes in membrane resistivity and 
capacitance using EIS.
Neither the mobility of the lipid probes nor their photophysical properties were altered on exposure of 
bilayer to Ibu, Levo or Pef. However, a modest decrease in the membrane resistivity was observed for 
each, indicating these drugs adsorb primarily at the membrane-aqueous interface with relatively weak 
penetration into the bilayer. The quenching of BODIPY fluorescence signal indicated that Dic and Rif 
pass through the membrane whilst membrane resistivity decreases very significantly in the presence of 
Dic indicating ion leakiness/porosity of the membrane is increased on binding by Dic and Rif. In the case 
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of the ATTO probe, faster mobility and α above 1 suggested that the membrane surface was partially 
disrupted, plausibly by direct interactions of the probe with Dic at the interface. 
Overall, our data suggest that Dic and Rif interact with the lipid head groups, perturbing the membrane 
packing and permeating across the membrane, whereas other drugs more likely reside on the membrane-
water interface. Our data are consistent with previous reports that Ibu, Levo and Pef are poorly passively 
permeable at a lipid bilayer whereas Dic and Rif display significant passive permeation. The relative 
changes in membrane resistivity can be fitted to a Langmuir-Freundlich Isotherms which provides 
empirical quantitative insight into the relative strength of the interaction of each drug with the membrane. 
The interaction of Rif with the membrane was strongly dependent on the lipid composition; for binary and 
ternary mixtures of DOPC:DOPG:DOPS, the lateral mobility of ATTO was 4 times less than for DOPC 
lipid alone for Rif permeation. In the case of Alen and Clo no changes to lipid mobility or membrane 
resistivity were observed up to very high concentrations. These drugs are strongly hydrophilic and 
believed to permeate through a paracellular pathway, which requires minimal or no interaction with the 
lipid membrane. 
Overall, the reported data are consistent with literature mechanisms proposed for drug-membrane 
interactions suggesting that MSLB models are a useful platform to study the interaction of drugs with the 
physiological membrane.
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